Who Paid My Doc
David Guzman
Internal Medicine Los Angeles, CA Medical Doctor
NPI 1275521494 CMS profile 797899
6041 Cadillac Ave, Los Angeles, CA 90034
General payments
$14,343
Research payments
$4,501
Ownership & investment interest
$0
Research they led as principal investigator
$4,311,350
Through program year 2025, David Guzman of Los Angeles, CA is reported in the CMS Open Payments database as having received $14,343 across 93 general payments and $4,501 in research payments paid to them. Separately, studies naming them as principal investigator received $4,311,350 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $4,632 | 18 | |
| 2024 | General | $6,428 | 47 | |
| 2024 | Research | $2,947 | 16 | |
| 2023 | General | $3,209 | 24 | |
| 2023 | Research | $1,554 | 9 | |
| 2022 | General | $19 | 1 | |
| 2020 | General | $20 | 1 | |
| 2019 | General | $34 | 2 |
Beside peers
- David Guzman
- Internal Medicine median
- Middle half of Internal Medicine
- National median
In program year 2025, general payments to David Guzman were reported at $4,632. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.
Show as a table
| Year | David Guzman | Internal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $34 | $159 | $48–$570 | $163 |
| 2020 | $20 | $119 | $33–$402 | $114 |
| 2021 | $0 | $135 | $37–$521 | $132 |
| 2022 | $19 | $141 | $42–$496 | $149 |
| 2023 | $3,209 | $149 | $45–$519 | $160 |
| 2024 | $6,428 | $154 | $47–$537 | $164 |
| 2025 | $4,632 | $156 | $47–$551 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
118 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Internal Medicine in California
Andrew Cheng
Internal Medicine · South San Francisco, CA
Tung Ngo
Internal Medicine · Newport Beach, CA
Christian Eversull
Internal Medicine · Stanford, CA
Christian Sandrock
Internal Medicine · Sacramento, CA
Hatim Husain
Internal Medicine · San Diego, CA
Teck Ling
Internal Medicine · Palo Alto, CA
Related records
Internal Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Internal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.